These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11774126

  • 1. Combined use of enalapril and losartan to reduce proteinuria: a question of safety.
    Ellis D.
    Am J Kidney Dis; 2002 Jan; 39(1):209-11. PubMed ID: 11774126
    [No Abstract] [Full Text] [Related]

  • 2. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 3. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M.
    Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG, Balestracci A, Missoni M, Vezzani C.
    Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
    [Abstract] [Full Text] [Related]

  • 5. IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
    Reddan DN, Owen WF.
    Am J Kidney Dis; 2001 Jul; 38(1):182-5. PubMed ID: 11431200
    [No Abstract] [Full Text] [Related]

  • 6. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 7. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 8. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 May; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 9. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 May; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 10. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL, Nicolay K, Koomans HA, Joles JA.
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
    Kuriyama S, Tomonari H, Abe A, Imasawa T, Hosoya T.
    Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
    [No Abstract] [Full Text] [Related]

  • 12. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W, Lee S, Kang SK, Yu HC, Cho BH, Park SK.
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract] [Full Text] [Related]

  • 13. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
    Cetinkaya R, Odabas AR, Selcuk Y.
    Int J Clin Pract; 2004 May; 58(5):432-5. PubMed ID: 15206496
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic resistance to ACEI and ARB combination in macroalbuminuric diabetic nephropathy.
    Futrakul N, Futrakul P.
    Clin Nephrol; 2012 Sep; 78(3):250. PubMed ID: 22541688
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 16. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 18. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
    Kuwabara Y, Komuro I.
    Nihon Naika Gakkai Zasshi; 2005 Feb 10; 94(2):255-61. PubMed ID: 15768589
    [No Abstract] [Full Text] [Related]

  • 19. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.
    Titan SM, M Vieira J, Dominguez WV, Barros RT, Zatz R.
    Clin Nephrol; 2011 Oct 10; 76(4):273-83. PubMed ID: 21955862
    [Abstract] [Full Text] [Related]

  • 20. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J.
    Rev Med Chil; 2000 Feb 10; 128(2):211-2. PubMed ID: 10962891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.